Form 4 for NVCR NovoCure Ltd
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-03 · accession 0001645113-21-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-04 | 2021-08-03 | NVCR | Benaim Ely | Chief Medical Off | S - Sale | $150.11 | -464 | 28.1K | -2% | -$69.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-03 | S | D | 464 | $150.11 | 28,144 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. |